Statement by FTC Chairman Jon Leibowitz on Adoption of the Pay for Delay Amendment to the Americas Affordable Health Choices Act of 2009 by the House Energy and Commerce Committee

Posted byIR Press Leave a comment on Statement by FTC Chairman Jon Leibowitz on Adoption of the Pay for Delay Amendment to the Americas Affordable Health Choices Act of 2009 by the House Energy and Commerce Committee

I commend the House Energy and Commerce Committee for adopting the Protecting Consumer Access to Generic Drugs Act (H.R.1706) as an amendment to the omnibus health reform legislation. If enacted into law, this measure will put an end to the sweetheart deals between brand and generic pharmaceutical companies that force consumers to wait –sometimes years– for more affordable generic drugs. We estimate that this critical provision will save consumers about $3.5 billion per year and advance the cause of affordable health care for all Americans.

(PayForDelay.wpd)

Related posts:

  1. FTC Files Amicus Brief in Support of Rehearing of Ciprofloxacin “Pay-for-Delay” Case; FTC Approves Final Rule to Inform Consumers About Deposit Institutions That Lack Federal Deposit Insurance
  2. Statement by FTC Chairman Jon Leibowitz Regarding Today’s District Court Decision Denying a Motion to Dismiss the Commission’s Pay-For-Delay Case Against Cephalon Inc.
  3. FTC Chairman Leibowitz: Eliminating Pay-for-Delay Pharmaceutical Settlements Would Save Consumers $3.5 Billion Annually
  4. FTC Testifies in Support of Bill Banning Pay-for-Delay Settlements Between Brand and Generic Drug Companies

Leave a comment

Your email address will not be published. Required fields are marked *